Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The aim of this study was to assess the effect of leucine supplementation on elements of the ubiquitin–proteasome system (UPS) in rat skeletal muscle during immobilization. This effect was evaluated by submitting the animals to a leucine supplementation protocol during hindlimb immobilization, after which different parameters were determined, including: muscle mass; cross‐sectional area (CSA); gene expression of E3 ligases/deubiquitinating enzymes; content of ubiquitinated proteins; and rate of protein synthesis. Our results show that leucine supplementation attenuates soleus muscle mass loss driven by immobilization. In addition, the marked decrease in the CSA in soleus muscle type I fibers, but not type II fibers, induced by immobilization was minimized by leucine feeding. Interestingly, leucine supplementation severely minimized the early transient increase in E3 ligase [muscle ring finger 1 (MuRF1) and muscle atrophy F‐box (MAFbx)/atrogin‐1] gene expression observed during immobilization. The reduced peak of E3 ligase gene expression was paralleled by a decreased content of ubiquitinated proteins during leucine feeding. The protein synthesis rate decreased by immobilization and was not affected by leucine supplementation. Our results strongly suggest that leucine supplementation attenuates muscle wasting induced by immobilization via minimizing gene expression of E3 ligases, which consequently could downregulate UPS‐driven protein degradation. It is notable that leucine supplementation does not restore decreased protein synthesis driven by immobilization. Muscle Nerve, 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521 · cited 3×
“Evidence suggests that the enhancement of proteolysis in atrophying muscles results mainly from a general activation of the UPS protein degradation.(4,9,10) In various types of atrophy, including Cushing’s syndrome,(11) diabetes,(12) sepsis,(13) cancer cachexia,(14) and renal failure,(15) muscles exhibit a common seri…”
BackgroundMultiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539 · cited 1×
“In various types of atrophy, including Cushing’s syndrome,(11) diabetes,(12) sepsis,(13) cancer cachexia,(14) and renal failure,(15) muscles exhibit a common series of adaptations, including increased content of ubiquitin (Ub)–protein conjugates(16) and mRNA encoding Ub,(17) certain ubiquitination enzymes,(12) and mul…”
BackgroundSkeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106
Biolo, G., Maggi, S. P., Williams, B. D., Tipton, K. D., & Wolfe, R. R. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.3.e514 · Cited by 713 · cited 1×
“Possibilities include different fiber-type leucine uptake capacity and preferred metabolization of leucine by type I fibers.(36,37) In order to investigate the mechanisms associ-”
BackgroundAnthony, J. C., Anthony, T. G., Kimball, S. R., & Jefferson, L. S. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.3.856s · Cited by 434
Effect of limb immobilization on skeletal muscle
Booth, F. W. (1982) · Journal of Applied Physiology · doi:10.1152/jappl.1982.52.5.1113 · Cited by 331
Transmembrane transport and intracellular kinetics of amino acids in human skeletal muscle
Biolo, G., Fleming, R. Y., Maggi, S. P., & Wolfe, R. R. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.1.e75 · Cited by 287
Sensitivity of myofibrillar proteins to glucocorticoid-induced muscle proteolysis
Kayali, A. G., Young, V. R., & Goodman, M. N. (1987) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1987.252.5.e621 · Cited by 136
Cited by
Branched-chain amino acids in metabolic signalling and insulin resistance
Lynch, C. J., & Adams, S. H. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.171 · Cited by 1,461
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bodine, S. C., & Baehr, L. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2014 · Cited by 1,113
The Emerging Role of Branched-Chain Amino Acids in Insulin Resistance and Metabolism
Yoon, M.-S. (2016) · Nutrients · doi:10.3390/nu8070405 · Cited by 430
The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass
Rom, O., & Reznick, A. Z. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.031 · Cited by 256
Nutritional Support for Exercise-Induced Injuries
Tipton, K. D. (2015) · Sports Medicine · doi:10.1007/s40279-015-0398-4 · Cited by 147
“Leucine has been shown to restore impaired MPS in rats [81, 82] and ameliorates muscle loss in rats during immobilization [83].”
Background
Metadata
- Authors
- Baptista, I. L., Leal, M. L., Artioli, G. G., Aoki, M. S., Fiamoncini, J., Turri, A. O., Curi, R., Miyabara, E. H., & Moriscot, A. S.
- Venue
- Muscle & Nerve
- Publisher
- Wiley
- Published
- 2010-01-15
- Volume
- 41
- Issue
- 6
- Pages
- 800-808
- ISSN
- 0148-639X (ISSN-L)
- 1097-4598
- OpenAlex
- W2008352037
- Cited by
- 129
- References
- 8
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases. https://app.cochat.ai/papers/10.1002/mus.21578
- The paper
- Baptista, I. L., Leal, M. L., Artioli, G. G., Aoki, M. S., Fiamoncini, J., Turri, A. O., Curi, R., Miyabara, E. H., & Moriscot, A. S. (2010). Leucine attenuates skeletal muscle wasting via inhibition of ubiquitin ligases. Muscle & Nerve. https://doi.org/10.1002/mus.21578
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.